Extract from Announcement:
"With the market for analgesics to treat neuropathic pain estimated at several billion dollars, an effective therapy could potentially reap similar rewards to the blockbuster COX-2-selective anti-inflammatory analgesics - such as Celebrex - which are
currently serving the arthritis pain market".
No wonder they are in a big hurry. That should strengthen the pipeline.
Gerry
Please do your own research and you decide if and when to buy, hold or sell any stocks.
+ + data and comment + +, page-6
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)